4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-012356
President and CEO gave up 2,633 shares (to pay taxes)
- President and CEO acquired 6,758 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jiang Wenbin President and CEO | 2023-02-21 | Option exercise | +6,758 | 7,727,072 | D | ||
| Jiang Wenbin President and CEO | 2023-02-21 | Shares withheld for taxes | −2,633 | $10.97 | $28,884 | 7,724,439 | D |
| Derivatives | |||||||
| Jiang Wenbin President and CEO | 2023-02-21 | Option exercise · Restricted Stock Units | −6,758 | 78,852 | D | ||
Loading xslF345X03/doc4.xml…